SCHEMBL321082

SCHEMBL321082

CCCCC(CCBr)C(=O)O

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA2 P00918 7/20 0.65
MAPK1 P28482 1/20 0.65
CHRM1 P11229 1/20 0.56
AKR1A1 P14550 1/20 0.56
CHRM3 P20309 1/20 0.56
HTR2A P28223 1/20 0.56
HTR2C P28335 1/20 0.56
ADRA1A P35348 1/20 0.56
HRH1 P35367 1/20 0.56
DRD3 P35462 1/20 0.56
SLC6A3 Q01959 1/20 0.56
HDAC1 Q13547 1/20 0.56
HDAC2 Q92769 1/20 0.56
TDP1 Q9NUW8 1/20 0.56
SLC1A2 P43004 2/20 0.55
SLC1A1 P43005 2/20 0.55
SLC1A3 P43003 1/20 0.55
GRIK1 P39086 2/20 0.48
GRIK2 Q13002 2/20 0.48
CA1 P00915 4/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22534499 0.92 GRIK1 (0.58) CA2MAPK1CHRM1AKR1A1CHRM3
SCHEMBL7776230 0.92 GRIK1 (0.58) CA2MAPK1CHRM1AKR1A1CHRM3
SCHEMBL6120281 0.92 GRIK1 (0.58) CA2MAPK1CHRM1AKR1A1CHRM3
SCHEMBL10562619 0.92 GRIK1 (0.58) CA2MAPK1CHRM1AKR1A1CHRM3
SCHEMBL847378 0.89 CA2 (0.63) CA2MAPK1CHRM1AKR1A1CHRM3
SCHEMBL593706 0.89 CA2 (0.81) CA2MAPK1CHRM1AKR1A1CHRM3
SCHEMBL27535823 0.86 CHRM1 (0.76) CA2MAPK1CHRM1AKR1A1CHRM3
SCHEMBL11662108 0.86 CA2 (0.77) CA2MAPK1CHRM1AKR1A1CHRM3
SCHEMBL14502406 0.86 CA2 (0.77) CA2MAPK1CHRM1AKR1A1CHRM3
SCHEMBL4623602 0.86 CA2 (0.77) CA2MAPK1CHRM1AKR1A1CHRM3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2590955-A1 SPIRO-CYCLIC AMINE DERIVATIVES AS S1P MODULATORS ABBVIE B.V. (NL) 2013-05-15 EP disclosed
WO-2012004378-A1 SPIRO-CYCLIC AMINE DERIVATIVES AS S1P MODULATORS ABBOTT HEALTHCARE PRODUCTS B.V. (NL) 2012-01-12 WO disclosed
EP-2328619-A2 POLYMERIC BENZYL CARBONATE-DERIVATIVES Baxter International Inc. (US) 2011-06-08 EP disclosed
WO-2010022320-A2 POLYMERIC BENZYL CARBONATE-DERIVATIVES BAXTER INTERNATIONAL INC. (US) 2010-02-25 WO disclosed
EP-0777656-B1 NOVEL DNA-TARGETED ALKYLATING AGENTS AUCKLAND DIVISION CANCER SOC O (NZ) 2004-04-14 EP disclosed
US-5968933-A ANTITUMOR AGENTS AND BINDING DNA FOR MUTAGENESIS AUCKLAND DIVISION CANCER SOCIETY OF NEW ZEALAND INC. (NZ) 1999-10-19 US disclosed
EP-0777656-A4 NOVEL DNA-TARGETED ALKYLATING AGENTS CANCER SOC AUCKLAND DIV NZ INC (NZ) 1998-04-15 EP disclosed
EP-0777656-A1 NOVEL DNA-TARGETED ALKYLATING AGENTS AUCKLAND DIVISION CANCER SOCIETY OF NEW ZEALAND (INCORPORATED) (NZ) 1997-06-11 EP disclosed
WO-1996006831-A1 NOVEL DNA-TARGETED ALKYLATING AGENTS AUCKLAND DIVISION CANCER SOCIETY OF NEW ZEALAND INC. (NZ) 1996-03-07 WO disclosed
EP-0299449-A2 Pyridazinone, triazinone and oxapyridazinone lipoxygenase inhibiting compounds ABBOTT LABORATORIES (US) 1989-01-18 EP disclosed